<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37592162</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-0100</ISSN><JournalIssue CitedMedium="Internet"><Volume>82</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Endocrine</Title><ISOAbbreviation>Endocrine</ISOAbbreviation></Journal><ArticleTitle>Lack of vitamin D predicts impaired long-term immune response to COVID-19 vaccination.</ArticleTitle><Pagination><StartPage>536</StartPage><EndPage>541</EndPage><MedlinePgn>536-541</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12020-023-03481-w</ELocationID><Abstract><AbstractText Label="PURPOSE">Low vitamin D levels were reported to negatively influence the outcome of acute COVID-19, as well as to be linked to Long-COVID. However, few studies have investigated, so far, its effects on humoral-response to anti-SARS-CoV-2 vaccination, reporting conflicting results. We aimed to evaluate the impact of baseline 25(OH)vitamin D (25(OH)D) levels on humoral-response to a two-dose cycle of Pfizer-BioNTech-vaccine up to 9-10 months after immunization.</AbstractText><AbstractText Label="METHODS">We retrospectively included 119 consecutive healthcare-workers (median age 53 years) without a previous history of acute COVID-19 or anti-SARS-CoV-2 immunoglobulins presence immunized with two doses of Comirnaty-vaccine from January to February 2021. 25(OH)D was measured at time of first-immunization. Immune response was evaluated at: time 0 (T0), before the first-dose; T1, time of second-dose (21 days after T0); T2, T3, T4 at 1, 5 and 9 months after T1, respectively.</AbstractText><AbstractText Label="RESULTS">Median 25(OH)D levels were 25.6&#x2009;ng/mL, and vitamin D deficiency (25(OH)D &lt;20 ng/mL) was observed in 29 subjects (24.8%). In those with vitamin D deficiency, we found a non-significant trend towards lower antibody-titers at T3, and significantly lower titers at T4 as compared to those not vitamin D-deficient, also observing a more pronounced antibody-titers negative drop from peak-T2 and T4 in those with vitamin D deficiency. A positive correlation between 25(OH)D levels and antibody-titers at T4 (p&#x2009;=&#x2009;0.043) was found. In multiple linear-regression analysis, 25(OH)D deficiency and older-age resulted as negative independent factors associated with antibody titer at T4 (p&#x2009;=&#x2009;0.026, p&#x2009;=&#x2009;0.004; respectively).</AbstractText><AbstractText Label="CONCLUSION">In our relatively young cohort presenting low prevalence of hypovitaminosis D, the long-term humoral response to anti-SARS-CoV-2 vaccination was negatively influenced by low baseline 25(OH)D. Vitamin D supplementation could be tested as a strategy to optimize the vaccination campaigns to prevent severe COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>di Filippo</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frara</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Terenzi</LastName><ForeName>Umberto</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nannipieri</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Research, Abiogen Pharma, Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locatelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory Medicine Service, IRCCS San Raffaele Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciceri</LastName><ForeName>Fabio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hematology and Bone Marrow Transplant Unit, San Raffaele Vita-Salute University and IRCCS Hospital, Milano, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giustina</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6783-3398</Identifier><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, San Raffaele Vita-Salute University and IRCCS Hospital, Milano, Italy. giustina.andrea@hsr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Endocrine</MedlineTA><NlmUniqueID>9434444</NlmUniqueID><ISSNLinking>1355-008X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Br J Clin Pharmacol. 2018 Oct;84(10):2194-2207. doi: 10.1111/bcp.13652</RefSource><PMID Version="1">29851137</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014611" MajorTopicYN="N">Vaccination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007109" MajorTopicYN="N">Immunity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Anti-COVID-19 vaccine</Keyword><Keyword MajorTopicYN="N">Anti-SARS-CoV-2 vaccine</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Hypovitaminosis D</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Vitamin D</Keyword></KeywordList><CoiStatement>Andrea Giustina is consultant for Abiogen Pharma S.p.A. and Takeda and received research grant to Institution from Takeda. Stefano Frara received research grants to Institution from Abiogen Pharma S.p.A. Fabrizio Nannipieri is an employee of Abiogen Pharma S.p.A. All other authors have no conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>2</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>18</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>17</Day><Hour>23</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37592162</ArticleId><ArticleId IdType="pmc">PMC10618322</ArticleId><ArticleId IdType="doi">10.1007/s12020-023-03481-w</ArticleId><ArticleId IdType="pii">10.1007/s12020-023-03481-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bouillon R, Marcocci C, Carmeliet G, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev. 2019;40(4):1109&#x2013;1151. doi: 10.1210/er.2018-00126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2018-00126</ArticleId><ArticleId IdType="pmc">PMC6626501</ArticleId><ArticleId IdType="pubmed">30321335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. Mechanisms in endocrinology: vitamin D and COVID-19. Eur. J. Endocrinol. 2020;183(5):R133&#x2013;R147. doi: 10.1530/EJE-20-0665.</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/EJE-20-0665</ArticleId><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Binkley N, De Luca HF, et al. Consensus and controversial aspects of vitamin D and COVID-19. J. Clin. Endocrinol. Metab. 2023;108(5):1034&#x2013;1042. doi: 10.1210/clinem/dgac719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgac719</ArticleId><ArticleId IdType="pubmed">36477486</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Formenti AM, Adler RA, et al. Vitamin D: dosing, levels, form, and route of administration: does one approach fit all? Rev. Endocr. Metab. Disord. 2021;22(4):1201&#x2013;1218. doi: 10.1007/s11154-021-09693-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11154-021-09693-7</ArticleId><ArticleId IdType="pmc">PMC8696970</ArticleId><ArticleId IdType="pubmed">34940947</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee MD, Lin CH, Lei WT, et al. Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A Systematic review and meta-analysis. Nutrients. 2018;10:409. doi: 10.3390/nu10040409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu10040409</ArticleId><ArticleId IdType="pmc">PMC5946194</ArticleId><ArticleId IdType="pubmed">29587438</ArticleId></ArticleIdList></Reference><Reference><Citation>Piec I, Cook L, Dervisevic S, et al. Age and vitamin D affect the magnitude of the antibody response to the first dose of the SARS-CoV-2 BNT162b2 vaccine. Curr. Res Transl. Med. 2022;70(3):103344. doi: 10.1016/j.retram.2022.103344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.retram.2022.103344</ArticleId><ArticleId IdType="pmc">PMC8923881</ArticleId><ArticleId IdType="pubmed">35390564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelini P, d&#x2019;Angelo P, Cereda E, et al. Association between vitamin D serum levels and immune response to the BNT162b2 vaccine for SARS-CoV-2. Biomedicines. 2022;10(8):1993. doi: 10.3390/biomedicines10081993.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10081993</ArticleId><ArticleId IdType="pmc">PMC9405810</ArticleId><ArticleId IdType="pubmed">36009540</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Faustini SE, Holt H, et al. Determinants of antibody responses to SARS-CoV-2 vaccines: population-based longitudinal study (COVIDENCE UK) Vaccines (Basel) 2022;10(10):1601. doi: 10.3390/vaccines10101601.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10101601</ArticleId><ArticleId IdType="pmc">PMC9610049</ArticleId><ArticleId IdType="pubmed">36298466</ArticleId></ArticleIdList></Reference><Reference><Citation>Sempos CT, Heijboer AC, Bikle DD, et al. Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D. Br. J. Clin. Pharm. 2018;84(10):2194&#x2013;2207. doi: 10.1111/bcp.13652.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcp.13652</ArticleId><ArticleId IdType="pmc">PMC6138489</ArticleId><ArticleId IdType="pubmed">29851137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari D, Clementi N, Criscuolo E, et al. Antibody Titer Kinetics and SARS-CoV-2 infections six months after administration with the BNT162b2 vaccine. Vaccines (Basel) 2021;9(11):1357. doi: 10.3390/vaccines9111357.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9111357</ArticleId><ArticleId IdType="pmc">PMC8620373</ArticleId><ArticleId IdType="pubmed">34835288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari D, Ambrosi A, Di Resta C, Tomaiuolo R, Locatelli M, Banfi G. Evaluation of antibody titer kinetics and SARS-CoV-2 infections in a large cohort of healthcare professionals ten months after administration of the BNT162b2 vaccine. J. Immunol. Methods. 2022;506:113293. doi: 10.1016/j.jim.2022.113293.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jim.2022.113293</ArticleId><ArticleId IdType="pmc">PMC9161676</ArticleId><ArticleId IdType="pubmed">35660546</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombini A, Vigan&#xf2; M, Tomaiuolo R, et al. Exploratory assessment of serological tests to determine antibody titer against SARS-CoV-2: appropriateness and limits. J. Clin. Lab Anal. 2022;36(5):e24363. doi: 10.1002/jcla.24363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.24363</ArticleId><ArticleId IdType="pmc">PMC9102736</ArticleId><ArticleId IdType="pubmed">35334493</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Giustina A. The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat. Rev. Endocrinol. 2021;17(8):445&#x2013;446. doi: 10.1038/s41574-021-00516-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41574-021-00516-y</ArticleId><ArticleId IdType="pmc">PMC8170860</ArticleId><ArticleId IdType="pubmed">34079100</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Doga M, Giustina A. The osteo-metabolic phenotype of COVID-19: an update. Endocrine. 2022;78(2):247&#x2013;254. doi: 10.1007/s12020-022-03135-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03135-3</ArticleId><ArticleId IdType="pmc">PMC9297261</ArticleId><ArticleId IdType="pubmed">35857271</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Allora A, Doga M, et al. Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J. Clin. Endocrinol. Metab. 2022;107(1):e348&#x2013;e360. doi: 10.1210/clinem/dgab599.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab599</ArticleId><ArticleId IdType="pmc">PMC8385994</ArticleId><ArticleId IdType="pubmed">34383926</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchings N, Babalyan V, Baghdasaryan S, et al. Patients hospitalized with COVID-19 have low levels of 25-hydroxyvitamin D. Endocrine. 2021;71(2):267&#x2013;269. doi: 10.1007/s12020-020-02597-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-020-02597-7</ArticleId><ArticleId IdType="pmc">PMC7811339</ArticleId><ArticleId IdType="pubmed">33452994</ArticleId></ArticleIdList></Reference><Reference><Citation>L. di Filippo, S. Frara, F. Nannipieri et al. Low vitamin D levels are associated with long COVID syndrome in COVID-19 survivors J. Clin. Endocrinol. Metab. dgad207 (2023). 10.1210/clinem/dgad207</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="pubmed">37051747</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Uygur M, Locatelli M, Nannipieri F, Frara S, Giustina A. Low vitamin D levels predict outcomes ofCOVID-19 in patients with both severe and non-severe disease at hospitalization. Endocrine. Endocrine. 2023;80(3):669&#x2013;683. doi: 10.1007/s12020-023-03331-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03331-9</ArticleId><ArticleId IdType="pmc">PMC9974397</ArticleId><ArticleId IdType="pubmed">36854858</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine. 2021;72(2):301&#x2013;316. doi: 10.1007/s12020-021-02734-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-021-02734-w</ArticleId><ArticleId IdType="pmc">PMC8105151</ArticleId><ArticleId IdType="pubmed">33963516</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bouillon R, Binkley N, et al. Controversies in vitamin D: a statement from the third international conference. JBMR Plus. 2020;4(12):e10417. doi: 10.1002/jbm4.10417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm4.10417</ArticleId><ArticleId IdType="pmc">PMC7745884</ArticleId><ArticleId IdType="pubmed">33354643</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat. Med. 2021;27(7):1205&#x2013;1211. doi: 10.1038/s41591-021-01377-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01377-8</ArticleId><ArticleId IdType="pubmed">34002089</ArticleId></ArticleIdList></Reference><Reference><Citation>Earle KA, Ambrosino DM, Fiore-Gartland A, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423&#x2013;4428. doi: 10.1016/j.vaccine.2021.05.063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2021.05.063</ArticleId><ArticleId IdType="pmc">PMC8142841</ArticleId><ArticleId IdType="pubmed">34210573</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Liu S, Li F, et al. Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis. Front. Immunol. 2022;13:965971. doi: 10.3389/fimmu.2022.965971.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.965971</ArticleId><ArticleId IdType="pmc">PMC9513208</ArticleId><ArticleId IdType="pubmed">36177017</ArticleId></ArticleIdList></Reference><Reference><Citation>Babel N, Hugo C, Westhoff TH. Vaccination in patients with kidney failure: lessons from COVID-19. Nat. Rev. Nephrol. 2022;18(11):708&#x2013;723. doi: 10.1038/s41581-022-00617-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41581-022-00617-5</ArticleId><ArticleId IdType="pmc">PMC9397175</ArticleId><ArticleId IdType="pubmed">35999285</ArticleId></ArticleIdList></Reference><Reference><Citation>Fendler A, de Vries EGE, GeurtsvanKessel CH, et al. COVID-19 vaccines in patients with cancer: immunogenicity, efficacy and safety. Nat. Rev. Clin. Oncol. 2022;19(6):385&#x2013;401. doi: 10.1038/s41571-022-00610-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41571-022-00610-8</ArticleId><ArticleId IdType="pmc">PMC8916486</ArticleId><ArticleId IdType="pubmed">35277694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Tong Y, Li D, Li J, Li Y. The impact of age difference on the efficacy and safety of COVID-19 vaccines: a systematic review and meta-analysis. Front. Immunol. 2021;12:758294. doi: 10.3389/fimmu.2021.758294.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.758294</ArticleId><ArticleId IdType="pmc">PMC8685545</ArticleId><ArticleId IdType="pubmed">34938287</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H, Bu F, Li L, Zhang X, Yan J, Huang T. COVID-19 vaccine response and safety in patients with cancer: an overview of systematic reviews. Front. Public Health. 2022;10:1072137. doi: 10.3389/fpubh.2022.1072137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1072137</ArticleId><ArticleId IdType="pmc">PMC9707626</ArticleId><ArticleId IdType="pubmed">36457318</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno NF, McAdams R, Goss JA, Galvan NTN. COVID-19 vaccine efficacy and immunogenicity in end-stage renal disease patients and kidney transplant recipients. Curr. Transpl. Rep. 2022;9(3):174&#x2013;184. doi: 10.1007/s40472-022-00366-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40472-022-00366-1</ArticleId><ArticleId IdType="pmc">PMC9051503</ArticleId><ArticleId IdType="pubmed">35506151</ArticleId></ArticleIdList></Reference><Reference><Citation>El Karoui K, De Vriese AS. COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment. Kidney Int. 2022;101(5):883&#x2013;894. doi: 10.1016/j.kint.2022.01.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.kint.2022.01.022</ArticleId><ArticleId IdType="pmc">PMC8842412</ArticleId><ArticleId IdType="pubmed">35176326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bortolini MJS, Petriz B, Mineo JR, Resende RO. Why physical activity should be considered in clinical trials for COVID-19 vaccines: a focus on risk groups. Int. J. Environ. Res. Public Health. 2022;19(3):1853. doi: 10.3390/ijerph19031853.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19031853</ArticleId><ArticleId IdType="pmc">PMC8834774</ArticleId><ArticleId IdType="pubmed">35162875</ArticleId></ArticleIdList></Reference><Reference><Citation>Post N, Eddy D, Huntley C, et al. Antibody response to SARS-CoV-2 infection in humans: a systematic review. PLoS One. 2020;15(12):e0244126. doi: 10.1371/journal.pone.0244126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244126</ArticleId><ArticleId IdType="pmc">PMC7775097</ArticleId><ArticleId IdType="pubmed">33382764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chvatal-Medina M, Mendez-Cortina Y, Pati&#xf1;o PJ, Velilla PA, Rugeles MT. Antibody responses in COVID-19: a review. Front. Immunol. 2021;12:633184. doi: 10.3389/fimmu.2021.633184.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.633184</ArticleId><ArticleId IdType="pmc">PMC8081880</ArticleId><ArticleId IdType="pubmed">33936045</ArticleId></ArticleIdList></Reference><Reference><Citation>Latifi-Pupovci H, Namani S, Pajaziti A, et al. Relationship of anti-SARS-CoV-2 IgG antibodies with vitamin D and inflammatory markers in COVID-19 patients. Sci. Rep. 2022;12(1):5699. doi: 10.1038/s41598-022-09785-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-09785-7</ArticleId><ArticleId IdType="pmc">PMC8982653</ArticleId><ArticleId IdType="pubmed">35383273</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bouillon R, Dawson-Hughes B, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79(1):31&#x2013;44. doi: 10.1007/s12020-022-03208-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-022-03208-3</ArticleId><ArticleId IdType="pmc">PMC9607753</ArticleId><ArticleId IdType="pubmed">36287374</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>